معرفی
Zhengkang Luo is a Grant Holder at the Department of Organismal Biology; Evolution and Development at Uppsala University. His research focuses on immunological mechanisms underlying autoimmune diseases, particularly Type 1 diabetes and related complications. He investigates cytokine therapies, regulatory immune cells, and molecular pathways involved in disease progression.
- Key research areas include interleukin therapies, macrophage polarization, regulatory T/B cells, and immune cell kinetics in diabetes models.
- Collaborates with researchers such as Kailash Singh, Mariela Mejia Cordova, and Charlotte Soläng on immunomodulatory strategies and biomarker discovery.
His work combines experimental models (e.g., NOD mice) with advanced techniques like flow cytometry and molecular gene delivery. Recent studies emphasize IL-35's role in maintaining immune tolerance and preventing autoimmune diabetes.
Luo has authored/co-authored over 15 peer-reviewed articles in journals like International Journal of Molecular Sciences, Frontiers in Immunology, and Nature. His doctoral thesis (2023) details immunological strategies targeting IL-35-producing regulatory cells.
No scientific awards are explicitly mentioned, though his work has been published in high-impact journals and cited across multiple platforms including Mendeley and news outlets.
